IFP Advisors’s Ionis Pharmaceuticals IONS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$48.8K Sell
904
-246
-21% -$13.3K ﹤0.01% 2065
2025
Q1
$42.4K Hold
1,150
﹤0.01% 1967
2024
Q4
$49.1K Sell
1,150
-76
-6% -$3.24K ﹤0.01% 1844
2024
Q3
$49.1K Buy
1,226
+156
+15% +$6.25K ﹤0.01% 1744
2024
Q2
$51K Hold
1,070
﹤0.01% 1671
2024
Q1
$46.4K Hold
1,070
﹤0.01% 1621
2023
Q4
$54.1K Sell
1,070
-71
-6% -$3.59K ﹤0.01% 1511
2023
Q3
$51.8K Sell
1,141
-14
-1% -$635 ﹤0.01% 1536
2023
Q2
$47.4K Sell
1,155
-814
-41% -$33.4K ﹤0.01% 1634
2023
Q1
$91.8K Sell
1,969
-2,869
-59% -$134K ﹤0.01% 1293
2022
Q4
$233K Sell
4,838
-951
-16% -$45.8K 0.01% 1282
2022
Q3
$279K Hold
5,789
0.01% 1234
2022
Q2
$279K Hold
5,789
0.01% 1115
2022
Q1
$279K Buy
5,789
+3,116
+117% +$150K 0.01% 1115
2021
Q4
$93K Buy
2,673
+953
+55% +$33.2K ﹤0.01% 1274
2021
Q3
$66K Buy
1,720
+541
+46% +$20.8K ﹤0.01% 1423
2021
Q2
$45K Buy
1,179
+881
+296% +$33.6K ﹤0.01% 1573
2021
Q1
$13K Sell
298
-83
-22% -$3.62K ﹤0.01% 2015
2020
Q4
$21K Sell
381
-518
-58% -$28.6K ﹤0.01% 1774
2020
Q3
$43K Sell
899
-207
-19% -$9.9K ﹤0.01% 1345
2020
Q2
$66K Sell
1,106
-8
-0.7% -$477 0.01% 1087
2020
Q1
$56K Sell
1,114
-415
-27% -$20.9K 0.01% 1061
2019
Q4
$92K Sell
1,529
-1,703
-53% -$102K 0.01% 986
2019
Q3
$192K Buy
+3,232
New +$192K 0.01% 781
2019
Q1
$3K Sell
40
-889
-96% -$66.7K ﹤0.01% 2010
2018
Q4
$48K Sell
929
-75
-7% -$3.88K ﹤0.01% 1627
2018
Q3
$52K Sell
1,004
-1,468
-59% -$76K ﹤0.01% 1866
2018
Q2
$103K Sell
2,472
-936
-27% -$39K ﹤0.01% 1451
2018
Q1
$171K Hold
3,408
0.01% 1060
2017
Q4
$171K Sell
3,408
-1,759
-34% -$88.3K 0.01% 1059
2017
Q3
$262K Sell
5,167
-513
-9% -$26K 0.01% 985
2017
Q2
$289K Sell
5,680
-871
-13% -$44.3K 0.01% 920
2017
Q1
$263K Sell
6,551
-2,483
-27% -$99.7K 0.01% 972
2016
Q4
$432K Buy
9,034
+721
+9% +$34.5K 0.02% 681
2016
Q3
$305K Buy
8,313
+1,207
+17% +$44.3K 0.02% 802
2016
Q2
$165K Buy
7,106
+7,066
+17,665% +$164K 0.01% 1075
2016
Q1
$3K Sell
40
-8,045
-100% -$603K ﹤0.01% 2010
2015
Q4
$501K Buy
+8,085
New +$501K 0.03% 497